A research peptide is a short chain of amino acids sold as a laboratory reagent rather than as a medicine. The phrase describes how a product is labelled and marketed — it is not a purity grade, not a manufacturing standard, and not a status any regulator confers. The only public evidence of what is in a given vial is a certificate of analysis naming a laboratory, a lot, a purity figure and a measured mass. This guide covers the vocabulary, how to read that document, and the five checks that separate a vendor publishing evidence from one publishing a PDF.
591 certificates · 55 vendors indexed · index current to 29 Aug 2026
The short answer
“Research peptide” is a labelling category, not a quality grade. No authority inspects the products sold under it, no specification defines it, and nothing about the phrase guarantees identity, purity or mass. The only public evidence of what is in a vial is a certificate of analysis — and a certificate is worth what its weakest field is worth: an unnamed laboratory, a missing lot number or an absent mass result each reduce the document to decoration.
Products indexed here are labeled by their vendors for laboratory research use only. PepIndex publishes no dosing information and no protocols, and makes no safety or efficacy claim about any substance.
A peptide is a short chain of amino acids — shorter than a protein, longer than a single residue. The ones in this market are synthesised chemically, purified, freeze-dried into a glass vial and sold as a lyophilised powder. That is a description of a manufacturing route, and it is the only thing every product in the category has in common.
What the word “research” adds is commercial, not chemical. It describes the terms on which a seller offers the vial: as a reagent, with no human-use claim attached. Two products carrying identical labels can be made in different facilities, to different specifications, tested by different laboratories to different standards — or not tested at all. The label is constant; everything behind it varies.
That matters more here than in most markets, because the usual proxies are absent. There is no brand whose reputation was built under regulatory supervision, no pharmacopoeial monograph a product is released against, and no inspection regime standing behind the packaging. What exists instead is documents — which is why this index is built out of them.
The phrase is applied by the seller. It is not granted, checked or withdrawn by any regulator, and it certifies nothing about the contents of the vial. It has a real legal function — it supports a claim that a product is not intended for human use — and no quality function whatsoever.
What it does
What it does not do
The practical consequence is narrow and worth stating plainly: the phrase says something about how a seller positions itself and nothing about what is in the vial. That second question has exactly one public answer — the certificate. The legal side is covered separately in are research peptides legal.
Most confusion in this market is vocabulary confusion, and two pairs of terms do most of the damage: purity against mass, and a laboratory named against a laboratory independent. Each term below links to its full definition in the glossary.
| Term | What it means |
|---|---|
| Certificate of analysis (COA) | A laboratory document reporting what was measured in one specific lot on one specific date. It is evidence about that lot only, never about the vendor as a whole. |
| Lot (batch) | One production run, identified by a lot number. A certificate that does not name a lot cannot be tied to the vial in front of you. |
| Purity | The percentage of the material that is the target peptide, usually measured by HPLC. It says nothing about how much material is in the vial. |
| Labeled mass | What the vial says it contains — 10 mg, for example. A claim by the vendor, not a measurement. |
| Assayed mass | What the laboratory actually measured in the vial. The number that decides whether the labeled mass was true. |
| Label discrepancy | The gap between labeled and assayed mass, as a percentage. A 10 mg vial assaying at 8.4 mg carries a 16% discrepancy. |
| Third-party testing | Testing by a laboratory independent of the seller. A certificate issued by the vendor itself is not third-party testing, whatever the header says. |
| ISO/IEC 17025 | The international competence standard for testing laboratories. An accredited lab has demonstrated it can produce technically valid results. |
| Lot-to-lot consistency | Whether results hold across several lots. One clean certificate can be a fluke; a run of them is a process. |
| Research use only (RUO) | A labelling posture applied by the seller. It is not a grade, not a certification, and not a status any regulator confers. |
A certificate of analysis establishes that one laboratory measured certain properties in one lot on one date. That sentence contains every limit worth knowing. It is not a statement about the vendor, about the product line, or about the vial that arrives six months later from a different production run.
Read in order, the fields answer four separate questions, and a weak answer to any one of them undermines the rest:
Who measured it
The laboratory named in the header, and whether it is independent of the seller. This field decides whether the document is evidence or self-assessment.
What was measured
The lot identifier and the compound. Without a lot number the result floats free of any particular batch, and cannot be matched to the vial received.
When it was measured
The assay date. A certificate from two years ago describes a production run that no longer exists, whatever the current listing says.
What was found
Purity as a percentage, and — critically — the quantitative mass result alongside the labeled mass. Purity without mass is half a measurement.
The field-by-field walkthrough, with a worked example from a record in this index, is in how to read a peptide certificate of analysis.
Purity is the number every vendor leads with, and it is close to useless for telling vendors apart. Of the 591 certificates indexed here, 97% report 99% or better. The median is 99.75%. The lowest figure published anywhere in the set is 90.0%.
That distribution is not a finding about how clean the market is. It is a finding about which documents get published. A vendor-published certificate is a certificate the vendor chose to publish, and a number nearly everyone reports cannot separate anyone.
Mass behaves differently, because it is harder to select for. Purity is a ratio — the proportion of the material that is the target compound — while mass is an amount, and the two are independent. A vial can assay at 99.5% purity and still contain a fraction of what its label claims. Across the same certificate set, 62% miss their labeled mass by more than 5%. Most of that is overfill — 301 certificates report more material than the label claims, against 63 reporting less — but the spread is the point: 34 report an assayed mass below 90% of what the vial states.
The one-line version
Purity says how clean the material is. Mass says how much of it there is. Almost every vendor publishes the first; the ones worth comparing publish both.
Each of these is verifiable from a vendor’s own website in a few minutes, without trusting anything this index says. They are also, in roughly this order, what the scoring rubric weights most heavily.
Read the laboratory name on the certificate header, then compare it to the vendor. A lab field carrying the vendor’s own company name, a placeholder such as “independent lab”, or an individual’s name is not third-party testing. Accreditation is the question after that one, not before it.
The tell: The lab field is blank, generic, or matches the seller.
A certificate is evidence about one production run. If the document carries no lot identifier, or the identifier never appears on the product received, the document is decorative — it may be perfectly genuine and still say nothing about what was shipped.
The tell: One certificate is displayed for a product sold across many batches.
Purity is a ratio and mass is an amount; a vial can be 99.5% pure and contain half of what the label claims. Vendors that publish both numbers expose themselves to a check most of the market avoids. Vendors that publish purity alone have chosen the flattering half of the measurement.
The tell: The certificate reports purity but no quantitative mass result.
Openly published per-lot certificates, reachable without an account and without a support ticket, are the cheapest honesty signal in this market. Certificates available only on request are not worthless, but the friction is doing work for the seller.
The tell: An account or a support email is required before any document is visible.
A named legal entity, a physical address and a contact channel that reaches a person are the floor for accountability, not evidence of quality. Their absence does not prove bad faith. Their presence is what makes a complaint, a refund or a regulator’s letter possible at all.
The tell: No entity name anywhere on the site, and contact is a web form only.
Every indexed vendor is scored on published evidence of exactly these things, with each data point carrying its source and its capture date. The full ranking is at vendor rankings, and the vendors currently scoring highest are discussed in top vendors to buy peptides from.
These figures are computed from the index each time this page is rebuilt, not written into the prose. They describe what 55 vendors publish about themselves.
591
certificates indexed
Read field by field from 27 vendors, covering 35 compounds.
97%
report 99% purity or better
Median 99.75%. The lowest figure published anywhere in the set is 90.0%.
62%
miss their labeled mass by over 5%
301 report more material than the label claims and 63 report less; 34 fall below 90% of it.
11 of 55
have accreditation confirmed on a certificate
30 name a testing laboratory at all. 28 publish no certificate this index could read.
The shape of that is worth stating directly: this market is close to uniform on the number it advertises and highly variable on the ones it does not. 34 of 55 vendors publish certificates openly enough to be read without an account. How each observation becomes a score is set out in the methodology.
Compounds are grouped below by what the published literature examined — never by what anyone might use them for. Most substances in this market have been studied predominantly in animal models or cell culture, and a preclinical result is not a human result; that distinction is the subject of why animal results are not human results. Each compound page records the research located, the vendors indexed as carrying it, and the certificates held for it.
Literature concerns metabolic and endocrine pathways.
5-Amino-1MQAOD-9604ATX-304BAM15CagrilintideEloralintideHGH Fragment 176-191L-CarnitineMazdutideMetforminMOTS-cNAD+OrforglipronRetatrutideSemaglutideSLU-PP-332SLU-PP-915SurvodutideTesamorelinTesofensineTirzepatide
Literature concerns tissue repair models.
ARA-290BPC-157DSIPFollistatin-344GHRP-2GHRP-6HexarelinHGH (Somatropin)IGF-1 LR3KPVLarazotideLL-37Mecasermin (IGF-1)SermorelinSS-31TB-500ThymalinThymosin Alpha-1VIP
Literature concerns skin and cosmetic formulation.
Compounds that do not fall into the groups above.
AbaloparatideCerebrolysinCJC-1295DihexaEpithalonFOXO4-DRIGlutathioneHCGHumaninIpamorelinKisspeptinMenotropinsMethylene BlueOxytocinPE-22-28PinealonPT-141Rapamycin (Sirolimus)SelankSemaxTriptorelinVilon
Vials arrive as a lyophilised powder, and the arithmetic of turning a stated mass into a stated concentration is the one calculation this site provides — see the reconstitution calculator. It converts numbers; it recommends nothing.
No jurisdiction PepIndex covers bans research peptides as a category, and none grants them a category of their own. Each regulator asks the same first question — is this being placed on the market as a medicine? — and answers it from the seller’s own presentation and intended use rather than from the label. Supplying, advertising or importing a peptide for human use crosses the line in every jurisdiction covered. Australia and Canada go further and control certain ingredients directly, where relabelling has no effect at all.
Import is a separate act again, governed by separate rules, and the personal-use allowances people cite are narrower than their reputation. The statutory mechanism in each jurisdiction, with primary sources, is set out in are research peptides legal. Dated enforcement actions are tracked in the regulatory feed.
There is no dosing information on this site, no protocols, and no suggestion that any substance indexed here is safe or effective in a human being. That is not an oversight and it is not caution for its own sake — it is the boundary that makes the rest of the index worth reading. A reference work that also told readers what to take would be arguing for a conclusion while claiming to report evidence.
What this site does is narrower and checkable: it records what vendors publish, marks each claim as corroborated or merely recorded, dates it, links it to its source, and scores it on a published rubric. Where the evidence is missing, the profile says so rather than filling the gap. A fact here that is wrong or out of date can be corrected through contact, and vendors can submit their own documentation.
What are research peptides?
Research peptides are short chains of amino acids sold as laboratory reagents rather than as medicines. The phrase describes how a product is labelled and marketed — for laboratory research use only — not how it was manufactured, how pure it is, or who tested it. Two vials carrying the same label can differ in every measurable property.
What does “research use only” actually mean?
It is a label a seller applies, not a status a regulator confers. It can support a claim that a product is not intended for human use, but it certifies nothing about purity, identity, sterility or manufacturing standard, and it grants no permission. Where a substance is controlled at ingredient level — as under the Australian Poisons Standard or Canada’s Prescription Drug List — the label has no legal effect at all.
Are research peptides the same as pharmaceutical peptides?
No. A pharmaceutical peptide is manufactured under a regulated quality system, released against a specification, and authorised by a regulator for a stated use. A research-labelled peptide is released against whatever specification its seller chooses, and the only public evidence of what is in it is usually a certificate the seller commissioned and published. Where an approved counterpart exists, the trial literature describes that product, not the research-grade vial.
What does a certificate of analysis prove?
That one laboratory measured certain properties in one lot on one date — and only if the document is checkable. A certificate establishes nothing about a different lot, a later production run, or the vendor’s process in general. Its value depends entirely on who performed the assay, whether the lot is identified, and whether the reported mass matches the label.
Is 99% purity good?
It is unremarkable. Across the certificates indexed on PepIndex, the overwhelming majority report 99% or better, because a vendor-published certificate is a document the vendor chose to publish. A number nearly everyone reports cannot separate anyone. The fields that vary — the laboratory named, whether a lot is identified, and whether assayed mass matches labeled mass — are where the differences actually are.
What is the difference between labeled mass and assayed mass?
Labeled mass is what the vial claims to contain; assayed mass is what a laboratory measured in it. Purity is a ratio and tells you nothing about quantity, so the two numbers answer different questions. A vial can report 99.5% purity and contain substantially less — or more — active material than its label states.
Does the testing laboratory need to be accredited?
Accreditation to ISO/IEC 17025 means a laboratory has demonstrated it can produce technically valid results, which makes its certificates more load-bearing than an unaccredited lab’s. It is a strong signal rather than a strict requirement. The prior question is more basic: is a laboratory named at all, and is it independent of the seller.
How do I know if a peptide vendor is legitimate?
Judge the evidence a vendor publishes rather than the claims it makes. The five checks in this guide — a named independent laboratory, a matchable lot number, assayed mass alongside labeled mass, certificates readable without an account, and a named legal entity — are all verifiable from a vendor’s own site in a few minutes. PepIndex scores every indexed vendor on published evidence of exactly these things.
Are research peptides legal?
No jurisdiction PepIndex covers bans research peptides as a category, and none grants them a category of their own. What is regulated is supplying, advertising or importing a peptide as a medicine — and in Australia and Canada, additionally, whether the ingredient itself is scheduled or prescription-only. The jurisdiction-by-jurisdiction reading is a separate guide on this site.
Where should a beginner start?
Learn to read one certificate properly before comparing vendors, because every other signal in this market is downstream of that document. After that, the vendor rankings and the scoring methodology show which vendors publish evidence and how each criterion is weighted, and the compound pages record what published research exists for each substance.
Every product indexed on PepIndex is labeled by its vendor for laboratory research use only. Nothing on this page is medical advice, a recommendation of human use, or a dosing or protocol suggestion — PepIndex publishes none of that anywhere, and makes no safety or efficacy claim about any substance. The figures quoted are computed from certificates the vendors themselves published, and describe those documents rather than the products behind them. See the full disclosure and terms.